CTS communications distributed on July 6th and July 20th. In working with Grifols on the availability of ZIKV test reagents, CTS projects that you should be prepared to convert from a ZIKV clinical trial test to a licensed test as early as October 29, 2018. The communication includes a quick survey link and instructions to register for the upcoming webinar.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm thi...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
Celebrate National Blood Donor Month throughout January by inviting eligible individuals to donate b...